Companies Dominating the Stem Cell Treatment Landscape
- Stemedica Cell Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pluristem Therapeutics Inc.
- Thermo Fisher Scientific
- Becton, Dickinson and Company
- Advanced Cell Technology Inc.
- Cellular Engineering Technologies Inc.
- CellGenix GmbH
- PromoCell GmbH
- Kite Pharma
- Genea Biocells
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Stem Cell Treatment Market is evaluated at USD 382.53 million.
The global stem cell treatment market size exceeded USD 343.26 million in 2024 and is projected to expand at a CAGR of more than 14.3%, crossing USD 1.95 billion by 2037.
North America is anticipated to record USD 760.49 million by 2037, attributed to increasing awareness about stem cell treatments and rising chronic diseases.
The major players in the market include Stemedica Cell Technologies, Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Kite Pharma, Genea Biocells.
